Established in late 2009, the Office of the Chief Medical Officer (CMO) collaborates closely throughout the company to ensure we remain steadfast in our enduring commitment to patient safety and well being, and that we demonstrate this commitment through all of our decisions and actions.

Dr. Michael Rosenblatt, executive vice president and chief medical officer, leads this effort, representing the voice of the patient within Merck and serving as the primary voice of Merck to the global scientific and medical community. He advises senior leadership and the Merck Board of Directors on key medical matters and also serves as the company's medical spokesperson, communicating with global health stakeholders, including the media and policy-makers, about our products, our policy positions and other matters affecting patients.

Outside Merck, Dr. Rosenblatt and his team build collaborations and alliances, share ideas and exchange fresh insights so that Merck can better address health challenges through our innovations. Inside Merck, they provide medical and scientific perspective to inform research and development as well as commercial and corporate strategies, including our social responsibilities, and play a direct role in fostering scientific transparency, consumer and professional medical education and employee wellness.

Together, the CMO and his team play a unique role in helping Merck and Merck employees keep a sharp focus on patients in everything we do. The CMO represents a new role at Merck, but one that builds on the company's longstanding commitment to helping the world be well.